HIGH

Teva Metoprolol Succinate ER 100 mg Recall Expanded for Failed Dissolution Specifications (2026)

Teva Pharmaceuticals recalled 7,448 bottles of Metoprolol Succinate Extended-Release Tablets nationwide after failed dissolution specifications were identified. The recall involves 100 mg, 100‑tablet bottles (NDC 45963-677-11) and 1,000‑tablet bottles (NDC 45963-677-96). The defect may affect drug release and efficacy. Patients should stop using affected bottles and contact Teva or their clinician

Quick Facts at a Glance

Recall Date
January 29, 2026
Hazard Level
HIGH
Brands
METOPROLOL SUCCINATE, Actavis Pharma
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Failed Dissolution Specifications

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Teva Pharmaceuticals USA, Inc or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Metoprolol Succinate is a beta-blocker used to treat high blood pressure and heart-related conditions. It is sold as an extended-release tablet by Teva and other manufacturers as a prescription medicine.

Why This Is Dangerous

Dissolution failures can lead to inconsistent or insufficient drug release, potentially reducing efficacy or causing fluctuating drug levels in patients.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Patients taking affected lots may experience reduced blood pressure control or inconsistent therapeutic effects. There is no mention of acute injuries in the recall notice.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC 45963-677-11 or 45963-677-96 on bottle label.
  2. Check Lot numbers: 0718J251, 0729J251, 0730J251, Exp. 12/2026; 0718J252, 0729J252, 0730J252, Exp. 12/2026.
  3. Confirm distributed nationwide and Rx-only status.

Where to find product info

Recall details available at FDA enforcement report D-0356-2026 and Teva’s recall communications.

What timeline to expect

Refund or replacement timelines are not specified. Coordinate with your pharmacy and clinician.

If the manufacturer is unresponsive

  • Ask your pharmacist to escalate the issue to the prescribing clinician.
  • File a report with FDA MedWatch if drug safety concerns persist.

How to prevent similar issues

  • Always verify NDCs and lot numbers when receiving prescription medications.
  • Keep all recall notices and pharmacy receipts for reference.
  • Consult your clinician before stopping or changing any prescribed therapy.

Documentation advice

Keep bottle and recall notice, take photos of the label, retain serial codes and correspondence with Teva or the pharmacy.

Product Details

NDCs: 45963-677-11 (100 mg, 100-tablet bottles) and 45963-677-96 (1000-tablet bottles). Distribution: Nationwide. Quantity: 7,448 bottles. Sold as Rx Only. Brand: METOPROLOL SUCCINATE. Manufacturer: Teva Pharmaceuticals USA, Parsippany, NJ 07054.

Key Facts

  • 7,448 bottles recalled nationwide
  • NDCs: 45963-677-11 and 45963-677-96
  • Lot numbers: 0718J251, 0729J251, 0730J251, and 0718J252, 0729J252, 0730J252
  • Exp. date: 12/2026
  • Hazard: Failed dissolution specifications
  • Remedy: Stop use and contact Teva or healthcare provider

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
0718J251
0729J251
0730J251
0718J252
0729J252
+1 more
UPC Codes
45963-676
45963-709
45963-677
+8 more
Affected States
ALL
Report Date
March 11, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more